FLI 7 mg (Namenda XR 7 mg)
Generic Name: memantine
Pill imprint FLI 7 mg has been identified as Namenda XR 7 mg.
Namenda XR is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Namenda XR 7 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- memantine
- Imprint:
- FLI 7 mg
- Strength:
- 7 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Forest Pharmaceuticals, Inc.
More about Namenda XR (memantine)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
